Clinical Trial Update: Adalimumab-psoriasis and Small Bowel Lesions [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update indicating the study of adalimumab for plaque psoriasis and Crohn's disease with completion of the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Plaque Psoriasis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Innovaderm Research Inc. | Conditions: Plaque Psoriasis, Crohn's Disease | Phase 4 | Status: COMPLETED